These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 31703340)
1. Reductions of Circulating Nitric Oxide are Followed by Hypertension during Pregnancy and Increased Activity of Matrix Metalloproteinases-2 and -9 in Rats. Nascimento RA; Possomato-Vieira JS; Bonacio GF; Rizzi E; Dias-Junior CA Cells; 2019 Nov; 8(11):. PubMed ID: 31703340 [TBL] [Abstract][Full Text] [Related]
2. Hypertension, augmented activity of matrix metalloproteinases-2 and -9 and angiogenic imbalance in hypertensive pregnancy are attenuated by doxycycline. Nascimento RA; Possomato-Vieira JS; Gonçalves-Rizzi VH; Bonacio GF; Rizzi E; Dias-Junior CA Eur J Pharmacol; 2018 Dec; 840():60-69. PubMed ID: 30336141 [TBL] [Abstract][Full Text] [Related]
3. Angiogenic imbalance and diminished matrix metalloproteinase-2 and -9 underlie regional decreases in uteroplacental vascularization and feto-placental growth in hypertensive pregnancy. Dias-Junior CA; Chen J; Cui N; Chiang CL; Zhu M; Ren Z; Possomato-Vieira JS; Khalil RA Biochem Pharmacol; 2017 Dec; 146():101-116. PubMed ID: 28912068 [TBL] [Abstract][Full Text] [Related]
4. EMMPRIN-mediated induction of uterine and vascular matrix metalloproteinases during pregnancy and in response to estrogen and progesterone. Dang Y; Li W; Tran V; Khalil RA Biochem Pharmacol; 2013 Sep; 86(6):734-47. PubMed ID: 23856290 [TBL] [Abstract][Full Text] [Related]
5. Altered matrix metalloproteinase-2 and -9 expression/activity links placental ischemia and anti-angiogenic sFlt-1 to uteroplacental and vascular remodeling and collagen deposition in hypertensive pregnancy. Li W; Mata KM; Mazzuca MQ; Khalil RA Biochem Pharmacol; 2014 Jun; 89(3):370-85. PubMed ID: 24704473 [TBL] [Abstract][Full Text] [Related]
6. Sodium hydrosulfide prevents hypertension and increases in vascular endothelial growth factor and soluble fms-like tyrosine kinase-1 in hypertensive pregnant rats. Possomato-Vieira JS; Gonçalves-Rizzi VH; Graça TU; Nascimento RA; Dias-Junior CA Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1325-1332. PubMed ID: 27620880 [TBL] [Abstract][Full Text] [Related]
7. The role of nitric oxide on matrix metalloproteinase 2 (MMP2) and MMP9 in placenta and fetus from diabetic rats. Pustovrh MC; Jawerbaum A; White V; Capobianco E; Higa R; Martínez N; López-Costa JJ; González E Reproduction; 2007 Oct; 134(4):605-13. PubMed ID: 17890296 [TBL] [Abstract][Full Text] [Related]
8. The effects of sildenafil citrate on uterine angiogenic status and serum inflammatory markers in an L-NAME rat model of pre-eclampsia. Soobryan N; Murugesan S; Phoswa W; Gathiram P; Moodley J; Mackraj I Eur J Pharmacol; 2017 Jan; 795():101-107. PubMed ID: 27940055 [TBL] [Abstract][Full Text] [Related]
9. Long-term nitric oxide blockade in the pregnant rat: effects on blood pressure and plasma levels of endothelin-1. Edwards DL; Arora CP; Bui DT; Castro LC Am J Obstet Gynecol; 1996 Aug; 175(2):484-8. PubMed ID: 8765273 [TBL] [Abstract][Full Text] [Related]
10. Curcumin Prevents Renal Damage of l-NAME Induced Hypertension in by Reducing MMP-2 and MMP-9. Pereira BP; Silva AO; Awata WMC; Pimenta GF; Ribeiro JM; de Faria Almeida CA; Antonietto CRK; Dos Reis LFC; Esteves A; Torres LHL; de Araújo Paula FB; Ruginsk SG; Tirapelli CR; Rizzi E; Ceron CS Cell Biochem Funct; 2024 Sep; 42(7):e4119. PubMed ID: 39244707 [TBL] [Abstract][Full Text] [Related]
11. Angiostatin does not contribute to skeletal muscle microvascular rarefaction with low nitric oxide bioavailability. Frisbee JC; Samora JB; Basile DP Microcirculation; 2007 Feb; 14(2):145-53. PubMed ID: 17365669 [TBL] [Abstract][Full Text] [Related]
12. Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood-brain barrier permeability in focal cerebral ischemia and reperfusion injury. Gu Y; Zheng G; Xu M; Li Y; Chen X; Zhu W; Tong Y; Chung SK; Liu KJ; Shen J J Neurochem; 2012 Jan; 120(1):147-56. PubMed ID: 22007835 [TBL] [Abstract][Full Text] [Related]
13. Exogenous l-arginine reduces matrix metalloproteinase-2 and -9 activities and oxidative stress in patients with hypertension. Garcia VP; Rocha HNM; Silva GM; Amaral TAG; Secher NH; Nóbrega ACL; Vianna LC; Rocha NG Life Sci; 2016 Jul; 157():125-130. PubMed ID: 27287681 [TBL] [Abstract][Full Text] [Related]
14. Hydrogen sulfide ameliorated L-NAME-induced hypertensive heart disease by the Akt/eNOS/NO pathway. Jin S; Teng X; Xiao L; Xue H; Guo Q; Duan X; Chen Y; Wu Y Exp Biol Med (Maywood); 2017 Dec; 242(18):1831-1841. PubMed ID: 28971696 [TBL] [Abstract][Full Text] [Related]
15. Nobiletin alleviates vascular alterations through modulation of Nrf-2/HO-1 and MMP pathways in l-NAME induced hypertensive rats. Potue P; Wunpathe C; Maneesai P; Kukongviriyapan U; Prachaney P; Pakdeechote P Food Funct; 2019 Apr; 10(4):1880-1892. PubMed ID: 30864566 [TBL] [Abstract][Full Text] [Related]
16. Isoflurane increases the activity of the vascular matrix metalloproteinase-2 in non-pregnant rats and increases the nitric oxide metabolites in pregnancy. Souza CRR; Caetano ESP; Rodrigues SD; Lopes MC; Mattos BR; Santos ML; Rizzi E; Dias-Junior CA Biosci Rep; 2024 Jun; 44(6):. PubMed ID: 38757914 [TBL] [Abstract][Full Text] [Related]
17. Adrenomedullin attenuates the hypertension in hypertensive pregnant rats induced by N(G)-nitro-L-arginine methyl ester. Makino I; Shibata K; Makino Y; Kangawa K; Kawarabayashi T Eur J Pharmacol; 1999 Apr; 371(2-3):159-67. PubMed ID: 10357253 [TBL] [Abstract][Full Text] [Related]
18. Sodium nitrite attenuates hypertension-in-pregnancy and blunts increases in soluble fms-like tyrosine kinase-1 and in vascular endothelial growth factor. Gonçalves-Rizzi VH; Possomato-Vieira JS; Sales Graça TU; Nascimento RA; Dias-Junior CA Nitric Oxide; 2016 Jul; 57():71-78. PubMed ID: 27181106 [TBL] [Abstract][Full Text] [Related]
19. Effects of nitric oxide synthase inhibition on angiotensin receptors and metabolism in the pregnant hypertensive rat. Yang Y; Macdonald GJ; Duggan KA Clin Sci (Lond); 2001 Mar; 100(3):319-26. PubMed ID: 11222119 [TBL] [Abstract][Full Text] [Related]
20. Ca(2+)-insensitive vascular protein kinase C during pregnancy and NOS inhibition. Kanashiro CA; Alexander BT; Granger JP; Khalil RA Hypertension; 1999 Oct; 34(4 Pt 2):924-30. PubMed ID: 10523386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]